白细胞介素—2胸腔灌注治疗恶性胸水24例临床分析  

Clinical Analysis of 24 Cases of Malignant Pleural Effusion Perfused with Interleukin-2

作　　者：白春峰[1] 展钰可 周文丽[1] 考军[1] 于长青[1] 马红梅 (名隹)瑞云 

机构地区：[1]青岛市第二人民医院,266033

出　　处：《青岛医药卫生》1996年第3期37-38,共2页Qingdao Medical Journal

摘　　要：恶性胸腔积液能严重影响病人的呼吸循环功能,加速病人死亡。本文对24例恶性胸腔积液病人给予白细胞介素—2(IL-2)胸腔灌注治疗,取得了明显效果。其总有效率(完全缓解率+部分缓解率)较对照组有显著性差异(P<0.05),该作者认为该疗法治疗效果肯定,副作用轻,具有推广应用价值。Malignant pleural effusion can severely affect the function of respiration and circulation and increase the patient's death. It has obtained obvious effect for 24 cases of malignant pleural effusion treated by pleural cavity perfusion with Interleukin -2.Total response rate (CR+PR)was statistically more significant than the control group (P<0.05) The authors considered that this therapy was effective and safe in patients with advanced cancer complicated with malignant pleural effusion.

关 键 词：恶性胸腔积液 白细胞介素—2 

分 类 号：R730.5[医药卫生—肿瘤]